This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
CYP2C19 Genotypes
and you are
between 18 and 65
years old
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

The aim of this study is to investigate if the genetic variant CYP2C19*17 affects the pharmacokinetics of proguanil and clopidogrel.

Provided treatments

  • Drug: Proguanil
  • Drug: Clopidogrel

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01456546. The sponsor of the trial is University of Southern Denmark and it is looking for 31 volunteers for the current phase.
Official trial title:
Impact of CYP2C19*17 on the Pharmacokinetics of Proguanil and Clopidogrel